Preservation solution, preservation system and method for preserving biological tissues in vitro, in particular corneal tissues
US-2024172743-A1 · May 30, 2024 · US
US9315775B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9315775-B2 |
| Application number | US-201414307698-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2014 |
| Priority date | Mar 16, 2011 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This document provides methods and materials for enhancing the storage capabilities of red blood cell preparations. For example, methods and materials for using CO 2 to store red blood cells in a manner that (a) reduces the level of glucose or 2,3-DPG consumption of or reduces the level of 2,3-DPG production by a red blood cell preparation, (b) reduces the level of lactate formation by a red blood cell preparation, and/or (c) reduces the pH level of a red blood cell preparation are provided. Such methods and materials can result in prolonging the useful lifespan of the red blood cells of the red blood cell preparation. This document also provides methods and materials involved in prolonging useful storage of platelet preparations. For example, methods and materials for storing platelets in a manner that reduces platelet metabolism, that preserves platelet function, and/or that reduces the risk of bacterial contamination are provided.
Opening claim text (preview).
What is claimed is: 1. A method for treating a platelet concentrate, the method comprising: exposing a platelet concentrate to CO 2 gas under conditions wherein the pCO 2 level of said platelet concentrate is about 150 mmHg of pCO 2 to about 600 mmHg of pCO 2 . 2. The method of claim 1 , wherein said method comprises exposing said platelet concentrate to CO 2 gas under conditions wherein the pCO 2 level of said platelet concentrate is about 200 to about…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.